Status:
COMPLETED
A Targeted and Tailored Pharmacist Intervention to Improve Adherence to Antihypertensive Drugs Among Diabetes Patients
Lead Sponsor:
University of Groningen
Collaborating Sponsors:
Universitas Padjadjaran
Conditions:
Diabetes Mellitus, Type 2
Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary objective of this study is to assess the effect of a targeted and tailored pharmacist intervention on medication adherence among diabetes patients non-adherent to antihypertensive drugs. T...
Detailed Description
Adherence to chronic medication is often suboptimal. However, existing interventions to improve adherence are either too complex or expensive for implementation and scale-up in low-middle income count...
Eligibility Criteria
Inclusion
- At least 18 years old.
- Diagnosed with type 2 diabetes for at least one year based on patient's medical record.
- Using at least one antihypertensive drug in the last three months.
- Provision of signed informed consent.
- Have sub-optimal medication adherence to antihypertensive drugs according to the MARS (\<20).
Exclusion
- Patients with severe mental or physical constraints.
- Pregnancy or in the lactation period.
- Illiterate in Indonesian language.
- Enrollment in another intervention study.
- Those not responsible for taking their own medication
Key Trial Info
Start Date :
August 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2020
Estimated Enrollment :
113 Patients enrolled
Trial Details
Trial ID
NCT04023734
Start Date
August 16 2019
End Date
January 30 2020
Last Update
March 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Community Health Centers
Bandung, West Java, Indonesia